| Literature DB >> 36059284 |
Athanasios Pegios1, Dimitrios Kavvadas2, Konstantinos Ζarras3, Konstantia Mpani4, Prodromos Soukiouroglou4, Sofia Charalampidou4, Eleni Vagdatli5, Theodora Papamitsou6.
Abstract
Background: Electromagnetic non-ionizing radiation has both thermal and non-thermal outcomes on biological systems, such as humans, animals, and bacteria. Objective: This study aimed to investigate the effect of non-ionizing radiofrequency radiation, emitted by Wi-Fi routers, on bacterial strains and the modification of their susceptibility to modern antibiotics. Material andEntities:
Keywords: Anti-Bacterial Agents; Bacteria; Drug Resistance; Radiofrequency Radiation; Wi-Fi; Wireless Technology
Year: 2022 PMID: 36059284 PMCID: PMC9395630 DOI: 10.31661/jbpe.v0i0.2111-1433
Source DB: PubMed Journal: J Biomed Phys Eng ISSN: 2251-7200
Bacterial growth observed at each checkpoint from the beginning of the experiment. Experimental radiated group vs. control non-radiated group.
| Antibiotic Agent | Escherichia Coli | Klebsiella pneumoniae | Pseudomonas aeruginosa | Staphylococcus aureus | ||||
|---|---|---|---|---|---|---|---|---|
| *CTRL | *EXP | CTRL | EXP | CTRL | EXP | CTRL | EXP | |
|
| ||||||||
| TZP | 22 | 20 | 19 | 16 | 26 | R | 20 | 14 |
| IMI | R | R | R | R | R | R | R | R |
| LEV | 29 | 26 | 18 | 16 | 15 | 14 | R | R |
| ATM | 26 | 22 | 13 | 10 | 20 | R | R | R |
| CIP | 30 | 30 | 21 | 20 | 16 | 14 | 8 | R |
| CTX | 25 | 24 | 20 | 18 | 14 | R | 15 | 10 |
| COT | 24 | 22 | 18 | 14 | R | R | R | R |
| CRO | 26 | 22 | 17 | 14 | 15 | R | 14 | 12 |
|
| ||||||||
| TZP | 23 | 23 | 19 | 18 | 26 | 26 | 25 | 13 |
| IMI | R | R | R | R | R | R | 12 | R |
| LEV | 33 | 32 | 18 | 18 | 22 | 23 | 9 | R |
| ATM | 28 | 28 | 13 | 13 | 22 | 23 | R | R |
| CIP | 33 | 35 | 22 | 20 | 29 | 25 | 9 | R |
| CTX | 25 | 28 | 18 | 18 | 17 | 16 | 22 | 19 |
| COT | 24 | 25 | 15 | 15 | R | R | 22 | 22 |
| CRO | 25 | 28 | 15 | 17 | 18 | 15 | 20 | 18 |
|
| ||||||||
| TZP | 24 | 25 | 19 | 17 | 30 | 30 | 25 | 27 |
| IMI | R | R | R | R | R | R | 9 | 10 |
| LEV | 29 | 35 | 20 | 20 | 21 | 25 | 9 | 7 |
| ATM | 30 | 30 | 13 | 12 | 26 | 25 | R | R |
| CIP | 33 | 38 | 21 | 20 | 30 | 29 | 10 | 6 |
| CTX | 30 | 29 | 18 | 27 | 19 | 19 | 22 | 22 |
| COT | 24 | 26 | 15 | 14 | R | R | 22 | 23 |
| CRO | 28 | 30 | 16 | 17 | 21 | 19 | 20 | 19 |
|
| ||||||||
| TZP | 24 | 25 | 20 | 18 | 29 | 28 | 27 | 27 |
| IMI | R | R | R | R | R | R | 12 | 10 |
| LEV | 31 | 35 | 20 | 20 | 22 | 24 | 8 | 7 |
| ATM | 29 | 30 | 12 | 13 | 27 | 26 | R | R |
| CIP | 35 | 35 | 21 | 22 | 31 | 30 | 10 | R |
| CTX | 29 | 28 | 19 | 19 | 20 | 20 | 21 | 21 |
| COT | 24 | 25 | 13 | 13 | R | R | 23 | 25 |
| CRO | 28 | 30 | 16 | 17 | 21 | 21 | 19 | 19 |
|
| ||||||||
| TZP | 24 | 25 | 20 | 18 | 30 | 30 | 29 | 27 |
| IMI | R | 6 | R | R | 7 | 6 | 8 | 10 |
| LEV | 30 | 31 | 20 | 21 | 23 | 24 | 7 | 8 |
| ATM | 30 | 29 | 13 | 12 | 27 | 27 | R | 6 |
| CIP | 30 | 31 | 22 | 22 | 30 | 32 | 10 | 7 |
| CTX | 29 | 30 | 19 | 18 | 20 | 19 | 20 | 21 |
| COT | 23 | 25 | 11 | 12 | 6 | 6 | 23 | 25 |
| CRO | 30 | 31 | 17 | 17 | 23 | 20 | 18 | 19 |
|
| ||||||||
| TZP | 26 | 25 | 20 | 18 | 30 | 30 | 25 | 26 |
| IMI | 6 | 6 | 6 | 6 | 6 | 6 | 10 | 9 |
| LEV | 31 | 35 | 20 | 20 | 23 | 25 | 8 | 7 |
| ATM | 30 | 31 | 14 | 12 | 27 | 26 | 6 | 6 |
| CIP | 35 | 32 | 22 | 22 | 30 | 35 | 10 | 6 |
| CTX | 30 | 30 | 19 | 17 | 20 | 18 | 20 | 21 |
| COT | 23 | 23 | 11 | 10 | 6 | R | 22 | 24 |
| CRO | 30 | 31 | 17 | 16 | 20 | 20 | 19 | 19 |
TZP: Piperacillin-Tazobactam (110 μgr), IMI: Imipenem (10 μgr), CTX: Cefotaxime (30 μgr), CIP: Ciprofloxacin (5 μgr), ATM: Aztreonam (30 μgr), COT: Cotrimoxazole (25 μgr), LEV: Levofloxacin (5 μgr), CRO: Ceftriaxone (30 μgr), CTRL: Control Group, EXP: Experimental Group
Paired Samples Test Escherichia coli (with bold are highlighted the statistically significant differences).
| Paired Differences | t | df | Sig. (2-tailed) P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | Std. Deviation | Std. Error Mean | 95% Confidence Interval of the Difference | ||||||
| Lower | Upper | ||||||||
| Pair1 | *CTRL6 - EXP6 | 2.00000 | 1.60357 | 0.56695 | 0.65938 | 3.34062 | 3.528 | 7 |
|
| Pair2 | CTRL9 - EXP9 | -1.00000 | 1.51186 | 0.53452 | -2.26394 | 0.26394 | -1.871 | 7 | 0.104 |
| Pair3 | CTRL12 - EXP12 | -1.87500 | 2.47487 | 0.87500 | -3.94405 | 0.19405 | -2.143 | 7 | 0.069 |
| Pair4 | CTRL15 - EXP15 | -1.00000 | 1.51186 | 0.53452 | -2.26394 | 0.26394 | -1.871 | 7 | 0.104 |
| Pair5 | CTRL18 - EXP18 | -0.87500 | 0.83452 | 0.29505 | -1.57268 | -0.17732 | -2.966 | 7 |
|
| Pair 6 | CTRL24 - EXP24 | -0.25000 | 1.98206 | 0.70076 | -1.90705 | 1.40705 | -0.357 | 7 | 0.732 |
*CTRL#: Control Group #Hour, EXP#: Experimental Group #Hour
Paired Samples Test Klebsiella pneumοniae (with bold are highlighted the statistically significant differences).
| Paired Differences | t | df | Sig. (2-tailed) P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | Std. Deviation | Std. Error Mean | 95% Confidence Interval of the Difference | ||||||
| Lower | Upper | ||||||||
| Pair 1 | *CTRL6 - EXP6 | 2.25000 | 1.28174 | 0.45316 | 1.17844 | 3.32156 | 4.965 | 7 |
|
| Pair 2 | CTRL9 - EXP9 | 0.12500 | 1.12599 | 0.39810 | -0.81635 | 1.06635 | 0.314 | 7 | 0.763 |
| Pair 3 | CTRL12 - EXP12 | -0.62500 | 3.50255 | 1.23834 | -3.55321 | 2.30321 | -0.505 | 7 | 0.629 |
| Pair 4 | CTRL15 - EXP15 | -0.12500 | 0.99103 | 0.35038 | -0.95352 | 0.70352 | -0.357 | 7 | 0.732 |
| Pair 5 | CTRL18 - EXP18 | 0.25000 | 1.03510 | 0.36596 | -0.61536 | 1.11536 | 0.683 | 7 | 0.516 |
| Pair 6 | CTRL24 - EXP24 | 1.00000 | 0.92582 | 0.32733 | 0.22600 | 1.77400 | 3.055 | 7 |
|
*CTRL#: Control Group #Hour, EXP#: Experimental Group #Hour
Paired Samples Test Pseudomonas aeruginosa (with bold are highlighted the statistically significant differences).
| Paired Differences | t | df | Sig. (2-tailed) P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | Std. Deviation | Std. Error Mean | 95% Confidence Interval of the Difference | ||||||
| Lower | Upper | ||||||||
| Pair 1 | *CTRL6 - EXP6 | 7.25000 | 7.85130 | 2.77585 | 0.68615 | 13.81385 | 2.612 | 7 |
|
| Pair 2 | CTRL9 - EXP9 | 0.75000 | 1.83225 | 0.64780 | -0.78180 | 2.28180 | 1.158 | 7 | 0.285 |
| Pair 3 | CTRL12 - EXP12 | 0.00000 | 1.77281 | 0.62678 | -1.48211 | 1.48211 | 0.000 | 7 | 1.000 |
| Pair 4 | CTRL15 - EXP15 | 0.12500 | 0.99103 | 0.35038 | -0.70352 | 0.95352 | 0.357 | 7 | 0.732 |
| Pair 5 | CTRL18 - EXP18 | 0.25000 | 1.48805 | 0.52610 | -0.99404 | 1.49404 | 0.475 | 7 | 0.649 |
| Pair 6 | CTRL24 - EXP24 | -0.37500 | 2.19984 | 0.77776 | -2.21411 | 1.46411 | -0.482 | 7 | 0.644 |
*CTRL#: Control Group #Hour, EXP#: Experimental Group #Hour
Paired Samples Test Staphylococcus aureus (with bold are highlighted the statistically significant differences).
| Paired Differences | t | df | Sig. (2-tailed) P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | Std. Deviation | Std. Error Mean | 95% Confidence Interval of the Difference | ||||||
| Lower | Upper | ||||||||
| Pair 1 | *CTRL6 - EXP6 | 2.00000 | 2.44949 | 0.86603 | -0.04782 | 4.04782 | 2.309 | 7 |
|
| Pair 2 | CTRL9 - EXP9 | 4.00000 | 3.96412 | 1.40153 | 0.68591 | 7.31409 | 2.854 | 7 |
|
| Pair 3 | CTRL12 - EXP12 | 0.37500 | 1.92261 | 0.67975 | -1.23234 | 1.98234 | 0.552 | 7 | 0.598 |
| Pair 4 | CTRL15 - EXP15 | 0.75000 | 2.05287 | 0.72580 | -0.96624 | 2.46624 | 1.033 | 7 | 0.336 |
| Pair 5 | CTRL18 - EXP18 | -0.37500 | 1.84681 | 0.65295 | -1.91897 | 1.16897 | -0.574 | 7 | 0.584 |
| Pair 6 | CTRL24 - EXP24 | 0.25000 | 1.83225 | 0.64780 | -1.28180 | 1.78180 | 0.386 | 7 | 0.711 |
*CTRL#: Control Group #Hour, EXP#: Experimental Group #Hour
Figure 1Comparisons of the bacterial growth observed six (6) h from the beginning of the experiment. Exposed group vs. control group. The x-axis represents the 8 antibiotic agents selected and Y-axis stands for the mean inhibition zone of each pathogen.
Figure 2Mean inhibition zone diameter in the studied strains against four selected antibiotics during 24 hours.